Cargando cotizaciones...
Previsión
El precio objetivo medio de los analistas es de 2,09 € (-31,92 %). La mediana es de 2,09 € (-31,92 %).
| Comprar |
3 |
| Mantener |
9 |
| Vender |
3 |
Debates en la comunidad
Todavía no hay ninguna discusión sobre este activo.
Iniciar debateNoticias Ir al feed de noticias
Cronos Group hits 52-week high after strong Q2 results
The Cronos Group share rose to a 52-week high of $3.44, with a market capitalization of $1.25 billion and year-to-date performance of 25.86%. InvestingPro points to an overvaluation versus fair value. Cronos beat expectations in Q2 2026 with revenue of $53 million (expectation $44.73 million), adjusted EPS of $0.09 (expectation $0.01), gross profit of $28.5 million and adjusted EBITDA of $13.1 million; cash and investments amounted to $827 million, and $60 million in share buybacks were reported. » Más en de.investing.com
Cronos shares rise after Q2 results significantly beat expectations
Cronos reported Q2 EPS of $0.09 (consensus $0.01) and revenue of $53.0 million versus expected $44.73 million. The company reported record net revenue, gross profit and adjusted EBITDA, organic revenue growth of 51% and record sales in Israel, Canada and Germany. Cronos repurchased a total of 12.3 million shares in H1 2026. The strong company-specific metrics pushed the stock sharply higher in pre-market trading and brought it closer to its 52-week high. » Más en de.investing.com
Cronos Group names ATB Capital Markets as broker for share buyback program
Cronos Group has appointed ATB Capital Markets Corp. (ATB Cormark) as broker for share repurchases on the Toronto Stock Exchange and other Canadian trading systems, replacing Virtu Canada Corp. The company gave no details on the reasons, size or timing of the buyback program. Cronos has most recently pursued an aggressive buyback strategy, which coincided with a 49% share price increase last year; market capitalization is around USD 1.04 billion. » Más en de.investing.com
Cronos Group well above Q1 2026 forecasts; shares rise premarket
Cronos Group reported Q1 2026 EPS of $0.04 (expectation $0.02) and revenue of CAD 45.2 million, up 40% year over year. Gross profit rose to CAD 19.2 million, adjusted EBITDA to CAD 5.1 million, and the balance sheet remains debt-free. Growth was driven mainly by stronger sales in Canada and Israel. After the results, the stock climbed about 9.45% in premarket trading. » Más en de.investing.com
Cronos to release results for quarter ended 31 March 2026 on 11 May 2026
Cronos will publish results for the quarter ended 31 March 2026 on 11 May 2026. Two analysts expect earnings per share of an average of 0.005 USD, after 0.030 CAD in the year‑ago quarter. Three analysts see revenue in the report at about 42.2 million USD versus 46.3 million CAD a year earlier. Four analysts expect, on average, earnings per share of 0.060 USD and revenue of about 191.2 million USD for the current fiscal year (prior year 204.8 million CAD). » Más en finanzen.net
Datos financieros de la empresa
| (EUR) | septiembre de 2026 | YoY |
|---|---|---|
| Ingresos | 56,02 M | 80,90 % |
| Beneficio bruto | 28,5 M | 82,45 % |
| Beneficio neto | 12,19 M | 44,90 % |
| EBITDA | 16,85 M | 35,26 % |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 1123,3 M € |
Número de acciones | 366,47 M |
Máximo/mínimo de 52 semanas | 3,55 € - 2,07 € |
| Dividendos | No |
Beta | 1,20 |
Ratio P/E | 21,01 |
Ratio PEG | -0,01 |
Ratio P/B | 1,16 |
Ratio P/S | 6,00 |
Perfil de la empresa
Cronos Group Inc. opera como empresa de cannabinoides. Fabrica, comercializa y distribuye suplementos y productos cosméticos de cáñamo a través de canales de comercio electrónico, venta minorista y socios del sector hostelero, bajo las marcas Lord Jones y Happy Dance en Estados Unidos. La empresa también participa en el cultivo, la fabricación y la comercialización de cannabis y productos derivados del cannabis para los mercados médico y de uso adulto. Vende cannabis y productos de cannabis, entre ellos cannabis seco, pre-rolls, comestibles, concentrados y extractos de cannabis, a través de canales mayoristas y directos al cliente bajo su plataforma de bienestar, PEACE NATURALS; y opera con las marcas de uso adulto Spinach. También exporta cannabis seco y aceites de cannabis a Alemania, Israel y Australia. Cronos Group Inc. fue fundada en 2012 y tiene su sede en Toronto, Canadá.
| Nombre | Cronos |
| CEO | Michael Ryan Gorenstein |
| Sede | Stayner,
on Canadá |
| Sitio web | |
| Sector | Salud |
| Industria | Proveedores y servicios sanitarios |
| Salida a bolsa | 27/02/2018 |
| Empleados | 610 |
Deep Dive
Símbolos bursátiles
| Bolsa | Símbolo |
|---|---|
NASDAQ | CRON |
Toronto Stock Exchange | CRON.TO |
Frankfurt | 7CI.F |
Düsseldorf | 7CI.DU |
München | 7CI.MU |